Genomic Health, Inc. (NASDAQ: GHDX ) reported Q3 EPS of $0.11, $0.06 better than the analyst estimate of $0.05. Revenue for the quarter came in at $58.6 million versus the consensus estimate of $59.85 million.

For earnings history and earnings-related data on Genomic Health, Inc. (GHDX ) click here.

Earnings